Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Breast Cancer

Free Subscription Articles published in Breast Cancer Retrieve available abstracts of 152 articles: HTML format Text format

Single Articles

August 2019
1. LIN QY, Wang JQ, Wu LL, Zheng WE, et al
   miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2.
   Breast Cancer. 2019 Aug 13. pii: 10.1007/s12282-019-01002.
   PubMed     Text format     Abstract available
   
   
   
2. NAITO Y, Kai Y, Ishikawa T, Fujita T, et al
   Chemotherapy-induced nausea and vomiting in patients with breast cancer: a prospective cohort study.
   Breast Cancer. 2019 Aug 12. pii: 10.1007/s12282-019-01001.
   PubMed     Text format     Abstract available
   
   
   
3. ZHANG R, Gao P, Ding J, Li Z, et al
   Assessment of significant procedures in multigene molecular detection for breast cancer in clinical laboratories: from variant detection to targeted therapy.
   Breast Cancer. 2019 Aug 6. pii: 10.1007/s12282-019-01000.
   PubMed     Text format     Abstract available
   
   
   
4. IIOKA Y, Iwata T, Yamauchi H
   Developing a checksheet for breast cancer patients receiving endocrine therapy-examining reliability and validity.
   Breast Cancer. 2019 Aug 2. pii: 10.1007/s12282-019-00998.
   PubMed     Text format     Abstract available
   
   
   
5. IGUCHI-MANAKA A, Okumura G, Ichioka E, Kiyomatsu H, et al
   High expression of soluble CD155 in estrogen receptor-negative breast cancer.
   Breast Cancer. 2019 Aug 1. pii: 10.1007/s12282-019-00999.
   PubMed     Text format     Abstract available
   
   
   July 2019
6. NAKAGAWA A, Fujimoto H, Nagashima T, Sangai T, et al
   Histological features of skin and subcutaneous tissue in patients with breast cancer who have received neoadjuvant chemotherapy and their relationship to post-treatment edema.
   Breast Cancer. 2019 Jul 25. pii: 10.1007/s12282-019-00996.
   PubMed     Text format     Abstract available
   
   
   
7. HOJO T, Masuda N, Iwamoto T, Niikura N, et al
   Taxane-based combinations as adjuvant chemotherapy for node-positive ER-positive breast cancer based on 2004-2009 data from the Breast Cancer Registry of the Japanese Breast Cancer Society.
   Breast Cancer. 2019 Jul 20. pii: 10.1007/s12282-019-00997.
   PubMed     Text format     Abstract available
   
   
   
8. IIOKA Y, Iwata T, Yamauchi H
   Symptoms and QOL in breast cancer patients receiving hormone therapy in Japan.
   Breast Cancer. 2019 Jul 11. pii: 10.1007/s12282-019-00993.
   PubMed     Text format     Abstract available
   
   
   
9. MOON G, Noh H, Cho IJ, Lee JI, et al
   Prediction of late recurrence in patients with breast cancer: elevated neutrophil to lymphocyte ratio (NLR) at 5 years after diagnosis and late recurrence.
   Breast Cancer. 2019 Jul 6. pii: 10.1007/s12282-019-00994.
   PubMed     Text format     Abstract available
   
   
   
10. YAO Z, Zheng X, Lu S, He Z, et al
    Knockdown of FAM64A suppresses proliferation and migration of breast cancer cells.
    Breast Cancer. 2019 Jul 1. pii: 10.1007/s12282-019-00991.
    PubMed     Text format     Abstract available
    
    
    June 2019
11. FURLANETTO J, von Minckwitz G, Lederer B, Mobus V, et al
    Fatal events during clinical trials: an evaluation of deaths during breast cancer studies.
    Breast Cancer. 2019 Jun 28. pii: 10.1007/s12282-019-00990.
    PubMed     Text format     Abstract available
    
    
    
12. ZHAO C, Ling X, Li X, Hou X, et al
    MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast cancer by directly targeting RHBDD1.
    Breast Cancer. 2019 Jun 26. pii: 10.1007/s12282-019-00989.
    PubMed     Text format     Abstract available
    
    
    
13. ZHAI Q, Li H, Sun L, Yuan Y, et al
    Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
    Breast Cancer. 2019 Jun 13. pii: 10.1007/s12282-019-00988.
    PubMed     Text format     Abstract available
    
    
    
14. DORRI S, Asadi F, Olfatbakhsh A, Kazemi A, et al
    A Systematic Review of Electronic Health (eHealth) interventions to improve physical activity in patients with breast cancer.
    Breast Cancer. 2019 Jun 12. pii: 10.1007/s12282-019-00982.
    PubMed     Text format     Abstract available
    
    
    
15. SHIMIZU C, Sakata Y, Sakai R, Ikezawa H, et al
    Pharmacotherapy decision-making among patients with breast cancer in Japan: results of an online survey.
    Breast Cancer. 2019 Jun 8. pii: 10.1007/s12282-019-00986.
    PubMed     Text format     Abstract available
    
    
    
16. SEKI H, Sakurai T, Mizuno S, Tokuda T, et al
    A novel nipple-areola complex involvement predictive index for indicating nipple-sparing mastectomy in breast cancer patients.
    Breast Cancer. 2019 Jun 8. pii: 10.1007/s12282-019-00987.
    PubMed     Text format     Abstract available
    
    
    
17. CHENG X, Tan S, Duan F, Yuan Q, et al
    Icariin induces apoptosis by suppressing autophagy in tamoxifen-resistant breast cancer cell line MCF-7/TAM.
    Breast Cancer. 2019 Jun 6. pii: 10.1007/s12282-019-00980.
    PubMed     Text format     Abstract available
    
    
    
18. MASUDA N, Mukai H, Inoue K, Rai Y, et al
    Correction to: Neutropenia management with palbociclib in Japanese patients with advanced breast cancer.
    Breast Cancer. 2019 Jun 5. pii: 10.1007/s12282-019-00984.
    PubMed     Text format     Abstract available
    
    
    
19. BEYAN C, Beyan E
    Mean platelet volume may not be an independent prognostic factor in breast cancer patients with type 2 diabetes mellitus.
    Breast Cancer. 2019 Jun 3. pii: 10.1007/s12282-019-00983.
    PubMed     Text format    
    
    
    May 2019
20. HAO R, Liu Y, Du Q, Liu L, et al
    Transgelin-2 expression in breast cancer and its relationships with clinicopathological features and patient outcome.
    Breast Cancer. 2019 May 29. pii: 10.1007/s12282-019-00981.
    PubMed     Text format     Abstract available
    
    
    
21. MANFUKU M, Nishigami T, Mibu A, Tanaka K, et al
    Comparison of central sensitization-related symptoms and health-related quality of life between breast cancer survivors with and without chronic pain and healthy controls.
    Breast Cancer. 2019 May 24. pii: 10.1007/s12282-019-00979.
    PubMed     Text format     Abstract available
    
    
    
22. MASUDA N, Mukai H, Inoue K, Rai Y, et al
    Neutropenia management with palbociclib in Japanese patients with advanced breast cancer.
    Breast Cancer. 2019 May 24. pii: 10.1007/s12282-019-00970.
    PubMed     Text format     Abstract available
    
    
    
23. TSUBOI K, Uematsu C, Yamaguchi Y, Niwa T, et al
    Tumor microenvironmental growth factors induce long-term estrogen deprivation resistance in breast cancer.
    Breast Cancer. 2019 May 22. pii: 10.1007/s12282-019-00978.
    PubMed     Text format     Abstract available
    
    
    
24. USISKIN I, Li F, Irwin ML, Cartmel B, et al
    Association between pre-diagnosis BMI, physical activity, pathologic complete response, and chemotherapy completion in women treated with neoadjuvant chemotherapy for breast cancer.
    Breast Cancer. 2019 May 22. pii: 10.1007/s12282-019-00974.
    PubMed     Text format     Abstract available
    
    
    
25. JONES LM, Stoner L, Brown C, Baldi JC, et al
    Cardiorespiratory fitness predicts cardiovascular health in breast cancer survivors, independent of body composition, age and time post-treatment completion.
    Breast Cancer. 2019 May 13. pii: 10.1007/s12282-019-00975.
    PubMed     Text format     Abstract available
    
    
    
26. LI N, Lv XH, Wang X, Wang RT, et al
    Preoperative mean platelet volume predicts survival in breast cancer patients with type 2 diabetes.
    Breast Cancer. 2019 May 13. pii: 10.1007/s12282-019-00976.
    PubMed     Text format     Abstract available
    
    
    
27. ROBERTSON JFR, Jiang Z, Di Leo A, Ohno S, et al
    A meta-analysis of clinical benefit rates for fulvestrant 500 mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancer.
    Breast Cancer. 2019 May 11. pii: 10.1007/s12282-019-00973.
    PubMed     Text format     Abstract available
    
    
    April 2019
28. MINAMI Y, Nishino Y, Kawai M, Tada H, et al
    Reproductive history and breast cancer survival: a prospective patient cohort study in Japan.
    Breast Cancer. 2019 Apr 15. pii: 10.1007/s12282-019-00972.
    PubMed     Text format     Abstract available
    
    
    
29. GAO X, Liu X, Lu Y, Wang Y, et al
    PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation.
    Breast Cancer. 2019 Apr 15. pii: 10.1007/s12282-019-00966.
    PubMed     Text format     Abstract available
    
    
    
30. SHIMADA S, Yoshida R, Nakashima E, Kitagawa D, et al
    Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers.
    Breast Cancer. 2019 Apr 12. pii: 10.1007/s12282-019-00971.
    PubMed     Text format     Abstract available
    
    
    
31. PAPANIKOLAOU IG, Dimitrakakis C, Zagouri F, Marinopoulos S, et al
    Paving the way for changing perceptions in breast surgery: a systematic literature review focused on oncological and aesthetic outcomes of oncoplastic surgery for breast cancer.
    Breast Cancer. 2019 Apr 6. pii: 10.1007/s12282-019-00968.
    PubMed     Text format     Abstract available
    
    
    
32. OMORI Y, Enatsu S, Cai Z, Ishiguro H, et al
    Patients' preferences for postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treatments in Japan.
    Breast Cancer. 2019 Apr 4. pii: 10.1007/s12282-019-00965.
    PubMed     Text format     Abstract available
    
    
    
33. KATO F, Kudo K, Yamashita H, Baba M, et al
    Predicting metastasis in clinically negative axillary lymph nodes with minimum apparent diffusion coefficient value in luminal A-like breast cancer.
    Breast Cancer. 2019 Apr 1. pii: 10.1007/s12282-019-00969.
    PubMed     Text format     Abstract available
    
    
    March 2019
34. LEE A, Jo S, Lee C, Shin HH, et al
    Diabetes as a prognostic factor in HER-2 positive breast cancer patients treated with targeted therapy.
    Breast Cancer. 2019 Mar 29. pii: 10.1007/s12282-019-00967.
    PubMed     Text format     Abstract available
    
    
    
35. HIRAOKA E, Mimae T, Ito M, Kadoya T, et al
    Correction to: Breast cancer cell motility is promoted by 14-3-3gamma.
    Breast Cancer. 2019 Mar 29. pii: 10.1007/s12282-019-00964.
    PubMed     Text format     Abstract available
    
    
    
36. PAN L, Ye C, Chen L, Tang W, et al
    Oncologic outcomes and radiation safety of nipple-sparing mastectomy with intraoperative radiotherapy for breast cancer.
    Breast Cancer. 2019 Mar 19. pii: 10.1007/s12282-019-00962.
    PubMed     Text format     Abstract available
    
    
    
37. KYRIAZOGLOU A, Zagouri F, Fotiou D, Dimitrakakis C, et al
    Discrepancies of current recommendations in breast cancer follow-up: a systematic review.
    Breast Cancer. 2019 Mar 18. pii: 10.1007/s12282-019-00963.
    PubMed     Text format     Abstract available
    
    
    
38. MENESES-SANCHEZ P, Garcia-Hernandez SC, Porchia LM, Perez-Fuentes R, et al
    C677T and A1298C methylenetetrahydrofolate reductase polymorphisms and breast cancer susceptibility among Latinos: a meta-analysis.
    Breast Cancer. 2019 Mar 15. pii: 10.1007/s12282-019-00961.
    PubMed     Text format     Abstract available
    
    
    
39. FUKUI K, Masumoto N, Shiroma N, Kanou A, et al
    Novel tumor-infiltrating lymphocytes ultrasonography score based on ultrasonic tissue findings predicts tumor-infiltrating lymphocytes in breast cancer.
    Breast Cancer. 2019 Mar 13. pii: 10.1007/s12282-019-00958.
    PubMed     Text format     Abstract available
    
    
    
40. HIRAOKA E, Mimae T, Ito M, Kadoya T, et al
    Breast cancer cell motility is promoted by 14-3-3gamma.
    Breast Cancer. 2019 Mar 4. pii: 10.1007/s12282-019-00957.
    PubMed     Text format     Abstract available
    
    
    February 2019
41. KOTANI H, Ito H, Kuwahara K, Kuzushima K, et al
    Impact of germinal center-associated nuclear protein polymorphisms on breast cancer risk and prognosis in a Japanese population.
    Breast Cancer. 2019 Feb 27. pii: 10.1007/s12282-019-00956.
    PubMed     Text format     Abstract available
    
    
    
42. LAI HL, Chen CI, Lu CY, Yao YC, et al
    Relationships among personality, coping, and concurrent health-related quality of life in women with breast cancer.
    Breast Cancer. 2019 Feb 12. pii: 10.1007/s12282-019-00954.
    PubMed     Text format     Abstract available
    
    
    
43. ISHIGURO H, Ohno S, Yamamoto Y, Takao S, et al
    Pharmacogenomic-pharmacokinetic study of selective estrogen-receptor modulators with intra-patient dose escalation in breast cancer.
    Breast Cancer. 2019 Feb 7. pii: 10.1007/s12282-019-00952.
    PubMed     Text format     Abstract available
    
    
    January 2019
44. BI Z, Liu J, Chen P, Liu Y, et al
    Neoadjuvant chemotherapy and timing of sentinel lymph node biopsy in different molecular subtypes of breast cancer with clinically negative axilla.
    Breast Cancer. 2019 Jan 21. pii: 10.1007/s12282-018-00934.
    PubMed     Text format     Abstract available
    
    
    
45. LIU L, Hu Y, Zhang S, Li X, et al
    Association of insulin-like growth factor 1 receptor and estrogen receptor with pathological complete response to neoadjuvant chemotherapy in HER2-negative breast cancer.
    Breast Cancer. 2019 Jan 8. pii: 10.1007/s12282-018-00939.
    PubMed     Text format     Abstract available
    
    
    
46. UCHIUMI K, Tsuboi K, Sato N, Ito T, et al
    Cancer stem-like properties of hormonal therapy-resistant breast cancer cells.
    Breast Cancer. 2019 Jan 4. pii: 10.1007/s12282-018-00944.
    PubMed     Text format     Abstract available
    
    
    
47. SHARMA R
    Breast cancer incidence, mortality and mortality-to-incidence ratio (MIR) are associated with human development, 1990-2016: evidence from Global Burden of Disease Study 2016.
    Breast Cancer. 2019 Jan 2. pii: 10.1007/s12282-018-00941.
    PubMed     Text format     Abstract available
    
    
    December 2018
48. KHADEMALHOSSEINI M, Arababadi MK
    Toll-like receptor 4 and breast cancer: an updated systematic review.
    Breast Cancer. 2018 Dec 12. pii: 10.1007/s12282-018-00935.
    PubMed     Text format     Abstract available
    
    
    November 2018
49. KANAYA N, Tanakaya K, Yamasaki R, Arata T, et al
    Clinicopathological features of breast cancer in Japanese female patients with Lynch syndrome.
    Breast Cancer. 2018 Nov 16. pii: 10.1007/s12282-018-0931.
    PubMed     Text format     Abstract available
    
    
    
50. WANG R, Li J, Yin C, Zhao D, et al
    Identification of differentially expressed genes and typical fusion genes associated with three subtypes of breast cancer.
    Breast Cancer. 2018 Nov 16. pii: 10.1007/s12282-018-0924.
    PubMed     Text format     Abstract available
    
    
    
51. ABBAS S, Siddique A, Shahid N, Khan RT, et al
    Breast cancer risk associated with BRCA1/2 variants in the Pakistani population.
    Breast Cancer. 2018 Nov 14. pii: 10.1007/s12282-018-0932.
    PubMed     Text format     Abstract available
    
    
    October 2018
52. HU K, He P, Peng Q, Zhong X, et al
    OFS plus AI or SERM vs. SERM alone in premenopausal women with hormone receptor-positive breast cancer: a prospective cohort study using the real-world database.
    Breast Cancer. 2018 Oct 26. pii: 10.1007/s12282-018-0929.
    PubMed     Text format     Abstract available
    
    
    
53. DEN OUDEN MEM, Pelgrum-Keurhorst MN, Uitdehaag MJ, De Vocht HM, et al
    Intimacy and sexuality in women with breast cancer: professional guidance needed.
    Breast Cancer. 2018 Oct 25. pii: 10.1007/s12282-018-0927.
    PubMed     Text format     Abstract available
    
    
    
54. RANGEL J, Tomas MT, Fernandes B
    Physical activity and physiotherapy: perception of women breast cancer survivors.
    Breast Cancer. 2018 Oct 25. pii: 10.1007/s12282-018-0928.
    PubMed     Text format     Abstract available
    
    
    
55. YAGI T, Fujiishi K, Hasegawa A, Otsuka T, et al
    Aldehyde dehydrogenase 2 genotype in tolerability of alcohol contained in paclitaxel in Japanese breast cancer patients.
    Breast Cancer. 2018 Oct 22. pii: 10.1007/s12282-018-0918.
    PubMed     Text format     Abstract available
    
    
    
56. LIU M, Zhou S, Wang J, Zhang Q, et al
    Identification of genes associated with survival of breast cancer patients.
    Breast Cancer. 2018 Oct 19. pii: 10.1007/s12282-018-0926.
    PubMed     Text format     Abstract available
    
    
    
57. PALUMBO I, Mariucci C, Falcinelli L, Perrucci E, et al
    Hypofractionated whole breast radiotherapy with or without hypofractionated boost in early stage breast cancer patients: a mono-institutional analysis of skin and subcutaneous toxicity.
    Breast Cancer. 2018 Oct 19. pii: 10.1007/s12282-018-0923.
    PubMed     Text format     Abstract available
    
    
    
58. IIDA M, Tsuboi K, Niwa T, Ishida T, et al
    Compensatory role of insulin-like growth factor 1 receptor in estrogen receptor signaling pathway and possible therapeutic target for hormone therapy-resistant breast cancer.
    Breast Cancer. 2018 Oct 16. pii: 10.1007/s12282-018-0922.
    PubMed     Text format     Abstract available
    
    
    
59. KWAPISZ D
    Oligometastatic breast cancer.
    Breast Cancer. 2018 Oct 15. pii: 10.1007/s12282-018-0921.
    PubMed     Text format     Abstract available
    
    
    
60. TSURUTANI J, Sakata Y, Matsuoka T
    Chemotherapy-induced peripheral neuropathy in breast cancer patients treated with eribulin: interim data from a post-marketing observational study.
    Breast Cancer. 2018 Oct 15. pii: 10.1007/s12282-018-0919.
    PubMed     Text format     Abstract available
    
    
    
61. SUZUKI E, Sugimoto M, Kawaguchi K, Pu F, et al
    Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients.
    Breast Cancer. 2018 Oct 13. pii: 10.1007/s12282-018-0920.
    PubMed     Text format     Abstract available
    
    
    
62. HASHEMI ZS, Forouzandeh Moghadam M, Khalili S, Ghavami M, et al
    Additive effect of metastamiR-193b and breast cancer metastasis suppressor 1 as an anti-metastatic strategy.
    Breast Cancer. 2018 Oct 3. pii: 10.1007/s12282-018-0915.
    PubMed     Text format     Abstract available
    
    
    September 2018
63. WANG X, Jia M, Li Y, Bao Y, et al
    Validation of an information-motivation-behavioral skills model of upper limb functional exercise adherence among Chinese postoperative patients with breast cancer.
    Breast Cancer. 2018 Sep 27. pii: 10.1007/s12282-018-0911.
    PubMed     Text format     Abstract available
    
    
    
64. NAKASHIMA K, Uematsu T, Takahashi K, Nishimura S, et al
    Does breast cancer growth rate really depend on tumor subtype? Measurement of tumor doubling time using serial ultrasonography between diagnosis and surgery.
    Breast Cancer. 2018 Sep 26. pii: 10.1007/s12282-018-0914.
    PubMed     Text format     Abstract available
    
    
    
65. MA Y, Wang Y, Song B
    Griffipavixanthone induces apoptosis of human breast cancer MCF-7 cells in vitro.
    Breast Cancer. 2018 Sep 26. pii: 10.1007/s12282-018-0912.
    PubMed     Text format     Abstract available
    
    
    
66. ZOHNY SF, Al-Malki AL, Zamzami MA, Choudhry H, et al
    p21(Waf1/Cip1): its paradoxical effect in the regulation of breast cancer.
    Breast Cancer. 2018 Sep 25. pii: 10.1007/s12282-018-0913.
    PubMed     Text format     Abstract available
    
    
    
67. ISHIGAMI E, Sakakibara M, Sakakibara J, Masuda T, et al
    Coexistence of regulatory B cells and regulatory T cells in tumor-infiltrating lymphocyte aggregates is a prognostic factor in patients with breast cancer.
    Breast Cancer. 2018 Sep 22. pii: 10.1007/s12282-018-0910.
    PubMed     Text format     Abstract available
    
    
    
68. TALIMA S, Kassem H, Kassem N
    Correction to: Chemotherapy and targeted therapy for breast cancer patients with hepatitis C virus infection.
    Breast Cancer. 2018 Sep 21. pii: 10.1007/s12282-018-0909.
    PubMed     Text format     Abstract available
    
    
    
69. OKUMATSU K, Tsujimoto T, Wakaba K, Seki A, et al
    Correction to: Effects of a combined exercise plus diet program on cardiorespiratory fitness of breast cancer patients.
    Breast Cancer. 2018 Sep 17. pii: 10.1007/s12282-018-0902.
    PubMed     Text format     Abstract available
    
    
    
70. KIKAWA Y, Hatachi Y, Rumpold G, Tokiwa M, et al
    Evaluation of health-related quality of life via the Computer-Based Health Evaluation System (CHES) for Japanese metastatic breast cancer patients: a single-center pilot study.
    Breast Cancer. 2018 Sep 7. pii: 10.1007/s12282-018-0905.
    PubMed     Text format     Abstract available
    
    
    
71. TALIMA S, Kaseem H, Kaseem N
    Chemotherapy and targeted therapy for breast cancer patients with hepatitis C virus infection.
    Breast Cancer. 2018 Sep 6. pii: 10.1007/s12282-018-0904.
    PubMed     Text format     Abstract available
    
    
    
72. ABU-KHALAF M, Muralikrishnan S, Hatzis C, Canchi D, et al
    Breast cancer patients with brain metastasis undergoing GKRS.
    Breast Cancer. 2018 Sep 4. pii: 10.1007/s12282-018-0903.
    PubMed     Text format     Abstract available
    
    
    
73. AYGIN D, Cengiz H
    Life quality of patients who underwent breast reconstruction after prophylactic mastectomy: systematic review.
    Breast Cancer. 2018;25:497-505.
    PubMed     Text format     Abstract available
    
    
    
74. SUGHAYER M, Alaaraj R, Alsughayer A
    Applying new Magee equations for predicting the Oncotype Dx recurrence score.
    Breast Cancer. 2018;25:597-604.
    PubMed     Text format     Abstract available
    
    
    
75. SAKAMOTO N, Fukuma E, Tsunoda Y, Teraoka K, et al
    Evaluation of the dislocation and long-term sonographic detectability of a hydrogel-based breast biopsy site marker.
    Breast Cancer. 2018;25:575-582.
    PubMed     Text format     Abstract available
    
    
    
76. ADACHI Y, Sawaki M, Hattori M, Yoshimura A, et al
    Comparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinoma.
    Breast Cancer. 2018;25:560-565.
    PubMed     Text format     Abstract available
    
    
    
77. GORCZYNSKI RM, Erin N, Maqbool T, Gorczynski CP, et al
    Characterization of an in vitro model system to explore control of tumor invasion of EMT6 and 4THM breast tumors by CD200:CD200R interactions.
    Breast Cancer. 2018;25:547-559.
    PubMed     Text format     Abstract available
    
    
    August 2018
78. AYGIN D, Bozdemir H
    Exposure to violence in breast cancer patients: systematic review.
    Breast Cancer. 2018 Aug 22. pii: 10.1007/s12282-018-0900.
    PubMed     Text format     Abstract available
    
    
    
79. NAGASAKA K, Satake H, Ishigaki S, Kawai H, et al
    Histogram analysis of quantitative pharmacokinetic parameters on DCE-MRI: correlations with prognostic factors and molecular subtypes in breast cancer.
    Breast Cancer. 2018 Aug 1. pii: 10.1007/s12282-018-0899.
    PubMed     Text format     Abstract available
    
    
    July 2018
80. ALTUNDAG K
    Younger breast cancer patients under the age of 35 might have a better disease-free survival if they received ovarian function suppression more than 3 years.
    Breast Cancer. 2018 Jul 28. pii: 10.1007/s12282-018-0897.
    PubMed     Text format    
    
    
    
81. NAKATSUKASA K, Koyama H, Ouchi Y, Ono H, et al
    Effect of denosumab on low bone mineral density in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: 24-month results.
    Breast Cancer. 2018 Jul 27. pii: 10.1007/s12282-018-0896.
    PubMed     Text format     Abstract available
    
    
    
82. AFTAB A, Shahzad S, Hussain HMJ, Khan R, et al
    CDKN2A/P16INK4A variants association with breast cancer and their in-silico analysis.
    Breast Cancer. 2018 Jul 23. pii: 10.1007/s12282-018-0894.
    PubMed     Text format     Abstract available
    
    
    
83. NOGUCHI E, Tamura K, Hattori M, Horiguchi J, et al
    Trastuzumab emtansine plus pertuzumab in Japanese patients with HER2-positive metastatic breast cancer: a phase Ib study.
    Breast Cancer. 2018 Jul 23. pii: 10.1007/s12282-018-0887.
    PubMed     Text format     Abstract available
    
    
    
84. LIU C, Liu Y, Chen L, Zhang M, et al
    Quantitative proteome and lysine succinylome analyses provide insights into metabolic regulation in breast cancer.
    Breast Cancer. 2018 Jul 18. pii: 10.1007/s12282-018-0893.
    PubMed     Text format     Abstract available
    
    
    
85. OKUMATSU K, Tsujimoto T, Wakaba K, Seki A, et al
    Effects of a combined exercise plus diet program on cardiorespiratory fitness of breast cancer patients.
    Breast Cancer. 2018 Jul 10. pii: 10.1007/s12282-018-0889.
    PubMed     Text format     Abstract available
    
    
    
86. MA D, Chen C, Wu J, Wang H, et al
    Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
    Breast Cancer. 2018 Jul 5. pii: 10.1007/s12282-018-0891.
    PubMed     Text format     Abstract available
    
    
    
87. TOKUNAGA E, Fujita A, Takizawa K, Baba K, et al
    CD44v9 as a poor prognostic factor of triple-negative breast cancer treated with neoadjuvant chemotherapy.
    Breast Cancer. 2018 Jul 3. pii: 10.1007/s12282-018-0888.
    PubMed     Text format     Abstract available
    
    
    
88. MACHIDA Y, Shimauchi A, Igarashi T, Hoshi K, et al
    Preoperative breast MRI: reproducibility and significance of findings relevant to nipple-areolar complex involvement.
    Breast Cancer. 2018;25:456-463.
    PubMed     Text format     Abstract available
    
    
    
89. SAIMURA M, Koga K, Anan K, Mitsuyama S, et al
    Diagnosis, characteristics, and treatment of breast carcinomas within benign fibroepithelial tumors.
    Breast Cancer. 2018;25:470-478.
    PubMed     Text format     Abstract available
    
    
    June 2018
90. PENG X, Yan B, Shen Y
    MiR-1301-3p inhibits human breast cancer cell proliferation by regulating cell cycle progression and apoptosis through directly targeting ICT1.
    Breast Cancer. 2018 Jun 27. pii: 10.1007/s12282-018-0881.
    PubMed     Text format     Abstract available
    
    
    
91. LIU L, Yin B, Yi Z, Liu X, et al
    Breast cancer stem cells characterized by CD70 expression preferentially metastasize to the lungs.
    Breast Cancer. 2018 Jun 14. pii: 10.1007/s12282-018-0880.
    PubMed     Text format     Abstract available
    
    
    
92. TAKABATAKE D, Kajiwara Y, Ohtani S, Itano Y, et al
    The efficacy and feasibility of dose-dense sequential chemotherapy for Japanese patients with breast cancer.
    Breast Cancer. 2018 Jun 11. pii: 10.1007/s12282-018-0877.
    PubMed     Text format     Abstract available
    
    
    
93. TOYAMA T, Yoshimura A, Hayashi T, Kobayashi N, et al
    A randomized phase II study evaluating pyridoxine for the prevention of hand-foot syndrome associated with capecitabine therapy for advanced or metastatic breast cancer.
    Breast Cancer. 2018 Jun 8. pii: 10.1007/s12282-018-0879.
    PubMed     Text format     Abstract available
    
    
    May 2018
94. LOUHICHI T, Ziadi S, Saad H, Dhiab MB, et al
    Clinicopathological significance of cancer stem cell markers CD44 and ALDH1 expression in breast cancer.
    Breast Cancer. 2018 May 29. pii: 10.1007/s12282-018-0875.
    PubMed     Text format     Abstract available
    
    
    
95. SAJI S
    The long and winding road for overcoming resistance to hormone therapy in breast cancer.
    Breast Cancer. 2018 May 28. pii: 10.1007/s12282-018-0876.
    PubMed     Text format    
    
    
    
96. GAO L, Li SC
    Cost-effectiveness analysis of lipegfilgrastim as primary prophylaxis in women with breast cancer in Australia: a modelled economic evaluation.
    Breast Cancer. 2018 May 25. pii: 10.1007/s12282-018-0872.
    PubMed     Text format     Abstract available
    
    
    
97. WEN L, Liu L, Wen L, Yu T, et al
    Artesunate promotes G2/M cell cycle arrest in MCF7 breast cancer cells through ATM activation.
    Breast Cancer. 2018 May 24. pii: 10.1007/s12282-018-0873.
    PubMed     Text format     Abstract available
    
    
    
98. OSTAPCHUK YO, Perfilyeva YV, Kustova EA, Urazalieva NT, et al
    Functional heterogeneity of circulating T regulatory cell subsets in breast cancer patients.
    Breast Cancer. 2018 May 24. pii: 10.1007/s12282-018-0874.
    PubMed     Text format     Abstract available
    
    
    
99. LEE SB, Sohn G, Kim J, Chung IY, et al
    Survival analysis according to period and analysis of the factors influencing changes in survival in patients with recurrent breast cancer: a large-scale, single-center study.
    Breast Cancer. 2018 May 21. pii: 10.1007/s12282-018-0869.
    PubMed     Text format     Abstract available
    
    
    
100. TAKADA M, Takeuchi M, Suzuki E, Sato F, et al
     Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence.
     Breast Cancer. 2018 May 9. pii: 10.1007/s12282-018-0868.
     PubMed     Text format     Abstract available
     
     
     
101. JAMAN MS, Sayeed MA
     Ellagic acid, sulforaphane, and ursolic acid in the prevention and therapy of breast cancer: current evidence and future perspectives.
     Breast Cancer. 2018 May 3. pii: 10.1007/s12282-018-0866.
     PubMed     Text format     Abstract available
     
     
     
102. GLOWACKA-MROTEK I, Sowa M, Nowikiewicz T, Siedlecki Z, et al
     Foot posture in female patients 5 years after breast-conserving surgery: a case-control study.
     Breast Cancer. 2018;25:325-333.
     PubMed     Text format     Abstract available
     
     
     April 2018
103. KWAPISZ D
     Cyclin-dependent kinase 4/6 inhibitors in hormone receptor-positive early breast cancer: preliminary results and ongoing studies.
     Breast Cancer. 2018 Apr 26. pii: 10.1007/s12282-018-0864.
     PubMed     Text format     Abstract available
     
     
     
104. SAKAI H, Tsurutani J, Iwasa T, Komoike Y, et al
     HER2 genomic amplification in circulating tumor DNA and estrogen receptor positivity predict primary resistance to trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer.
     Breast Cancer. 2018 Apr 26. pii: 10.1007/s12282-018-0861.
     PubMed     Text format     Abstract available
     
     
     
105. WANG NN, Yang ZJ, Wang X, Chen LX, et al
     A mathematical prediction model incorporating molecular subtype for risk of non-sentinel lymph node metastasis in sentinel lymph node-positive breast cancer patients: a retrospective analysis and nomogram development.
     Breast Cancer. 2018 Apr 25. pii: 10.1007/s12282-018-0863.
     PubMed     Text format     Abstract available
     
     
     
106. AOYAGI T, Takabe K, Tamanuki T, Matsubara H, et al
     Pseudocirrhosis after chemotherapy in breast cancer, case reports.
     Breast Cancer. 2018 Apr 25. pii: 10.1007/s12282-018-0865.
     PubMed     Text format     Abstract available
     
     
     
107. OHASHI R, Nagao M, Nakamura I, Okamoto T, et al
     Improvement in diagnostic performance of breast cancer: comparison between conventional digital mammography alone and conventional mammography plus digital breast tomosynthesis.
     Breast Cancer. 2018 Apr 12. pii: 10.1007/s12282-018-0859.
     PubMed     Text format     Abstract available
     
     
     
108. NAZARI SS, Mukherjee P
     An overview of mammographic density and its association with breast cancer.
     Breast Cancer. 2018 Apr 12. pii: 10.1007/s12282-018-0857.
     PubMed     Text format     Abstract available
     
     
     
109. LI Q, Gao H, Zhou S, Liao Y, et al
     LncRNA PlncRNA-1 overexpression inhibits the growth of breast cancer by upregulating TGF-beta1 and downregulating PHGDH.
     Breast Cancer. 2018 Apr 6. pii: 10.1007/s12282-018-0858.
     PubMed     Text format     Abstract available
     
     
     
110. IWASE M, Sawaki M, Hattori M, Yoshimura A, et al
     Assessing residual cancer cells using MRI and US after preoperative chemotherapy in primary breast cancer to omit surgery.
     Breast Cancer. 2018 Apr 4. pii: 10.1007/s12282-018-0856.
     PubMed     Text format     Abstract available
     
     
     March 2018
111. SASADA S, Shien T, Iwata H
     Current status of postmastectomy radiation therapy in T1-2 breast cancer with limited positive lymph nodes in Japan: Japan Clinical Oncology Group Survey.
     Breast Cancer. 2018 Mar 23. pii: 10.1007/s12282-018-0855.
     PubMed     Text format    
     
     
     
112. WAKABAYASHI H, Hamaguchi T, Nagao N, Kato S, et al
     Interleukin-6 receptor inhibitor suppresses bone metastases in a breast cancer cell line.
     Breast Cancer. 2018 Mar 19. pii: 10.1007/s12282-018-0853.
     PubMed     Text format     Abstract available
     
     
     
113. ZHANG JM, Wei K, Jiang M
     OCT4 but not SOX2 expression correlates with worse prognosis in surgical patients with triple-negative breast cancer.
     Breast Cancer. 2018 Mar 13. pii: 10.1007/s12282-018-0844.
     PubMed     Text format     Abstract available
     
     
     
114. YOSHIMURA A, Okumura S, Sawaki M, Hattori M, et al
     Feasibility study of contralateral risk-reducing mastectomy with breast reconstruction for breast cancer patients with BRCA mutations in Japan.
     Breast Cancer. 2018 Mar 8. pii: 10.1007/s12282-018-0850.
     PubMed     Text format     Abstract available
     
     
     
115. KA WH, Cho SK, Chun BN, Byun SY, et al
     The ubiquitin ligase COP1 regulates cell cycle and apoptosis by affecting p53 function in human breast cancer cell lines.
     Breast Cancer. 2018 Mar 7. pii: 10.1007/s12282-018-0849.
     PubMed     Text format     Abstract available
     
     
     February 2018
116. RAMOS-ESQUIVEL A, Hernandez-Steller H, Savard MF, Landaverde DU, et al
     Cyclin-dependent kinase 4/6 inhibitors as first-line treatment for post-menopausal metastatic hormone receptor-positive breast cancer patients: a systematic review and meta-analysis of phase III randomized clinical trials.
     Breast Cancer. 2018 Feb 22. pii: 10.1007/s12282-018-0848.
     PubMed     Text format     Abstract available
     
     
     
117. NOGUCHI S, Ellis MJ, Robertson JFR, Thirlwell J, et al
     Progression-free survival results in postmenopausal Asian women: subgroup analysis from a phase III randomized trial of fulvestrant 500 mg vs anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON).
     Breast Cancer. 2018 Feb 15. pii: 10.1007/s12282-018-0838.
     PubMed     Text format     Abstract available
     
     
     
118. MASUDA N, Toi M, Yamamoto N, Iwata H, et al
     Efficacy and safety of trastuzumab, lapatinib, and paclitaxel neoadjuvant treatment with or without prolonged exposure to anti-HER2 therapy, and with or without hormone therapy for HER2-positive primary breast cancer: a randomised, five-arm, multicent
     Breast Cancer. 2018 Feb 14. pii: 10.1007/s12282-018-0839.
     PubMed     Text format     Abstract available
     
     
     
119. CHEN W, Lv X, Xu X, Gao X, et al
     Meta-analysis for psychological impact of breast reconstruction in patients with breast cancer.
     Breast Cancer. 2018 Feb 13. pii: 10.1007/s12282-018-0846.
     PubMed     Text format     Abstract available
     
     
     
120. OHTANI S, Nakayama T, Yoshinami T, Watanabe KI, et al
     Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY).
     Breast Cancer. 2018 Feb 12. pii: 10.1007/s12282-018-0843.
     PubMed     Text format     Abstract available
     
     
     
121. SURYAVANSHI M, Mehta A, Jaipuria J, Kumar D, et al
     Clinical utility of RT-PCR in assessing HER 2 gene expression versus traditional IHC and FISH in breast cancer patients.
     Breast Cancer. 2018 Feb 9. pii: 10.1007/s12282-018-0840.
     PubMed     Text format     Abstract available
     
     
     
122. ZOU L, Liu FH, Shen PP, Hu Y, et al
     The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
     Breast Cancer. 2018 Feb 3. pii: 10.1007/s12282-018-0830.
     PubMed     Text format     Abstract available
     
     
     
123. IWATA H
     Clinical development of CDK4/6 inhibitor for breast cancer.
     Breast Cancer. 2018 Feb 1. pii: 10.1007/s12282-017-0827.
     PubMed     Text format     Abstract available
     
     
     January 2018
124. WANG Y, Wang J, Long F, Wang N, et al
     Correlation of FANCM expression with clinical factors in luminal B breast cancer.
     Breast Cancer. 2018 Jan 31. pii: 10.1007/s12282-018-0841.
     PubMed     Text format     Abstract available
     
     
     
125. KHAN RT, Siddique A, Shahid N, Khokher S, et al
     Breast cancer risk associated with genes encoding DNA repair MRN complex: a study from Punjab, Pakistan.
     Breast Cancer. 2018 Jan 24. pii: 10.1007/s12282-018-0837.
     PubMed     Text format     Abstract available
     
     
     
126. NGUYEN-THU H, Hanaoka H, Nakajima T, Yamaguchi A, et al
     Early prediction of triple negative breast cancer response to cisplatin treatment using diffusion-weighted MRI and (18)F-FDG-PET.
     Breast Cancer. 2018 Jan 22. pii: 10.1007/s12282-018-0834.
     PubMed     Text format     Abstract available
     
     
     
127. OZAKI Y, Tanabe Y, Tamura N, Ogura T, et al
     Impact on disease-free survival of the duration of ovarian function suppression, as postoperative adjuvant therapy, in premenopausal women with hormone receptor-positive breast cancer: a retrospective single-institution study.
     Breast Cancer. 2018 Jan 22. pii: 10.1007/s12282-018-0836.
     PubMed     Text format     Abstract available
     
     
     
128. YANG ZJ, Yu Y, Chi JR, Guan M, et al
     The combined pN stage and breast cancer subtypes in breast cancer: a better discriminator of outcome can be used to refine the 8th AJCC staging manual.
     Breast Cancer. 2018 Jan 20. pii: 10.1007/s12282-018-0833.
     PubMed     Text format     Abstract available
     
     
     
129. HABYARIMANA T, Attaleb M, Mazarati JB, Bakri Y, et al
     Detection of human papillomavirus DNA in tumors from Rwandese breast cancer patients.
     Breast Cancer. 2018 Jan 19. pii: 10.1007/s12282-018-0831.
     PubMed     Text format     Abstract available
     
     
     
130. INARI H, Shimizu S, Suganuma N, Yoshida T, et al
     Correction to: A comparison of clinicopathological characteristics and long-term survival outcomes between symptomatic and screen-detected breast cancer in Japanese women.
     Breast Cancer. 2018 Jan 10. pii: 10.1007/s12282-018-0832.
     PubMed     Text format     Abstract available
     
     
     
131. PIVOT X, Im SA, Guo M, Marme F, et al
     Subgroup analysis of patients with HER2-negative metastatic breast cancer in the second-line setting from a phase 3, open-label, randomized study of eribulin mesilate versus capecitabine.
     Breast Cancer. 2018 Jan 4. pii: 10.1007/s12282-017-0826.
     PubMed     Text format     Abstract available
     
     
     December 2017
132. PIERRISNARD C, Baciuchka M, Mancini J, Rathelot P, et al
     Body image and psychological distress in women with breast cancer: a French online survey on patients' perceptions and expectations.
     Breast Cancer. 2017 Dec 29. pii: 10.1007/s12282-017-0828.
     PubMed     Text format     Abstract available
     
     
     
133. ATTALLAH AM, El-Far M, Abdelrazek MA, Omran MM, et al
     HCV nonstructural protein 4 is associated with aggressiveness features of breast cancer.
     Breast Cancer. 2017 Dec 28. pii: 10.1007/s12282-017-0829.
     PubMed     Text format     Abstract available
     
     
     
134. SHIMOI T, Yoshida M, Kitamura Y, Yoshino T, et al
     TERT promoter hotspot mutations in breast cancer.
     Breast Cancer. 2017 Dec 8. pii: 10.1007/s12282-017-0825.
     PubMed     Text format     Abstract available
     
     
     
135. TSUDA B, Miyamoto A, Yokoyama K, Ogiya R, et al
     B-cell populations are expanded in breast cancer patients compared with healthy controls.
     Breast Cancer. 2017 Dec 4. pii: 10.1007/s12282-017-0824.
     PubMed     Text format     Abstract available
     
     
     
136. DORFEL S, Steffens CC, Meyer D, Tesch H, et al
     Adjuvant chemotherapeutic treatment of 1650 patients with early breast cancer in routine care in Germany: data from the prospective TMK cohort study.
     Breast Cancer. 2017 Dec 4. pii: 10.1007/s12282-017-0823.
     PubMed     Text format     Abstract available
     
     
     
137. HE J, Chen Y, Cai L, Li Z, et al
     UBAP2L silencing inhibits cell proliferation and G2/M phase transition in breast cancer.
     Breast Cancer. 2017 Dec 1. pii: 10.1007/s12282-017-0820.
     PubMed     Text format     Abstract available
     
     
     November 2017
138. INOUE H, Horii R, Ito Y, Iwase T, et al
     Tumor-infiltrating lymphocytes affect the efficacy of trastuzumab-based treatment in human epidermal growth factor receptor 2-positive breast cancer.
     Breast Cancer. 2017 Nov 28. pii: 10.1007/s12282-017-0822.
     PubMed     Text format     Abstract available
     
     
     
139. ZHANG ZL, Jiang QC, Wang SR
     Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
     Breast Cancer. 2017 Nov 27. pii: 10.1007/s12282-017-0821.
     PubMed     Text format     Abstract available
     
     
     
140. ZHAO Q, Song W, He DY, Li Y, et al
     Identification of key gene modules and pathways of human breast cancer by co-expression analysis.
     Breast Cancer. 2017 Nov 23. pii: 10.1007/s12282-017-0817.
     PubMed     Text format     Abstract available
     
     
     
141. HATTORI M, Ishiguro H, Masuda N, Yoshimura A, et al
     Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study.
     Breast Cancer. 2017 Nov 20. doi: 10.1007/s12282-017-0815.
     PubMed     Text format     Abstract available
     
     
     
142. KASSEM L, Shohdy KS, Lasheen S, Abdel-Rahman O, et al
     Hematological adverse effects in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis.
     Breast Cancer. 2017 Nov 16. doi: 10.1007/s12282-017-0818.
     PubMed     Text format     Abstract available
     
     
     
143. WANG R, Li J, Zhao Y, Li Y, et al
     Investigating the therapeutic potential and mechanism of curcumin in breast cancer based on RNA sequencing and bioinformatics analysis.
     Breast Cancer. 2017 Nov 14. doi: 10.1007/s12282-017-0816.
     PubMed     Text format     Abstract available
     
     
     
144. ADHAMI M, Haghdoost AA, Sadeghi B, Malekpour Afshar R, et al
     Candidate miRNAs in human breast cancer biomarkers: a systematic review.
     Breast Cancer. 2017 Nov 3. doi: 10.1007/s12282-017-0814.
     PubMed     Text format     Abstract available
     
     
     
145. SHIGEMATSU H, Ozaki S, Yasui D, Zaitsu J, et al
     Comparison of CK-IHC assay on serial frozen sections, the OSNA assay, and in combination for intraoperative evaluation of SLN metastases in breast cancer.
     Breast Cancer. 2017 Nov 1. doi: 10.1007/s12282-017-0811.
     PubMed     Text format     Abstract available
     
     
     
146. HARAO M, Ando J, Kamata H, Hoshi N, et al
     Peritoneal cancer arising after total abdominal hysterectomy and bilateral salpingo-oophorectomy for cervical cancer in a patient with right breast cancer and germline mutation of BRCA1 gene: a case report and literature review.
     Breast Cancer. 2017 Nov 1. doi: 10.1007/s12282-017-0813.
     PubMed     Text format     Abstract available
     
     
     October 2017
147. ARAKI K, Miyoshi Y
     Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer.
     Breast Cancer. 2017 Oct 31. doi: 10.1007/s12282-017-0812.
     PubMed     Text format     Abstract available
     
     
     
148. KHPAL M, Miller JRC, Petrovic Z, Hassanally D, et al
     Local anesthetic delivery via surgical drain provides improved pain control versus direct skin infiltration following axillary node dissection for breast cancer.
     Breast Cancer. 2017 Oct 26. doi: 10.1007/s12282-017-0810.
     PubMed     Text format     Abstract available
     
     
     
149. REGEV-AVRAHAM Z, Baron-Epel O, Hammond SK, Keinan-Boker L, et al
     Passive smoking, NAT2 polymorphism, and breast cancer risk in Israeli Arab women: a case-control study.
     Breast Cancer. 2017 Oct 26. doi: 10.1007/s12282-017-0809.
     PubMed     Text format     Abstract available
     
     
     
150. OGITA M, Nagura N, Kawamori J, In R, et al
     Risk factors for complications among breast cancer patients treated with post-mastectomy radiotherapy and immediate tissue-expander/permanent implant reconstruction: a retrospective cohort study.
     Breast Cancer. 2017 Oct 19. doi: 10.1007/s12282-017-0808.
     PubMed     Text format     Abstract available
     
     
     
151. TOYODA Y, Tabuchi T, Nakayama T, Hojo S, et al
     Trends in the clinical stage distribution of breast cancer in Osaka, Japan.
     Breast Cancer. 2017 Oct 12. doi: 10.1007/s12282-017-0807.
     PubMed     Text format     Abstract available
     
     
     September 2017
152. ALTUNDAG K
     Questions about lower inner zone tumors in early-stage breast cancer.
     Breast Cancer. 2017 Sep 14. doi: 10.1007/s12282-017-0801.
     PubMed     Text format    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: